{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T20:33:14Z","timestamp":1792528394614,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","award":["3719135"],"award-info":[{"award-number":["3719135"]}],"id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","award":["2127PRG"],"award-info":[{"award-number":["2127PRG"]}],"id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001515","name":"Cure Kids","doi-asserted-by":"publisher","award":["3619"],"award-info":[{"award-number":["3619"]}],"id":[{"id":"10.13039\/501100001515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001515","name":"Cure Kids","doi-asserted-by":"publisher","award":["5500"],"award-info":[{"award-number":["5500"]}],"id":[{"id":"10.13039\/501100001515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016905","name":"Hugh Green Foundation","doi-asserted-by":"publisher","award":["3712033"],"award-info":[{"award-number":["3712033"]}],"id":[{"id":"10.13039\/100016905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s13346-025-01850-8","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:46:03Z","timestamp":1744206363000},"page":"3950-3968","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["mPEG-PLA micelles for nose-to-brain delivery of crizotinib-heptamethine cyanine dye conjugate for potential treatment of glioblastoma"],"prefix":"10.1007","volume":"15","author":[{"given":"Harpinder Kaur","family":"Brar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas I.-H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina Jungha","family":"Dumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihwan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Mi","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Dragunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zimei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiney","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-3223","authenticated-orcid":false,"given":"Manisha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"3","key":"1850_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/cbdd.14171","volume":"101","author":"E Cooper","year":"2023","unstructured":"Cooper E, Choi PJ, Hwang K, et al. Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug-carrier molecule for the treatment of glioblastoma. Chem Biol Drug Des. 2023;101(3):696\u2013716.","journal-title":"Chem Biol Drug Des"},{"issue":"10","key":"1850_CR2","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.1021\/acs.molpharmaceut.3c00554","volume":"20","author":"Y Ale","year":"2023","unstructured":"Ale Y, Nainwal N. Progress and challenges in the diagnosis and treatment of brain cancer using nanotechnology. Mol Pharm. 2023;20(10):4893\u2013921.","journal-title":"Mol Pharm"},{"issue":"1","key":"1850_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/pharmaceutics15010059","volume":"15","author":"HK Brar","year":"2022","unstructured":"Brar HK, Jose J, Wu Z, et al. Tyrosine kinase inhibitors for glioblastoma multiforme: challenges and opportunities for drug delivery. Pharmaceutics. 2022;15(1):59.","journal-title":"Pharmaceutics"},{"issue":"23","key":"1850_CR4","first-page":"4312","volume":"24","author":"FA Bruinsmann","year":"2019","unstructured":"Bruinsmann FA, Richter Vaz G, de Cristo Soares Alves A, et al. Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: preclinical and clinical trials. Mol Basel Switz. 2019;24(23):4312.","journal-title":"Mol Basel Switz."},{"issue":"3","key":"1850_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11060-017-2388-x","volume":"132","author":"JC League-Pascual","year":"2017","unstructured":"League-Pascual JC, Lester-McCully CM, Shandilya S, et al. Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model. J Neurooncol. 2017;132(3):401\u20137.","journal-title":"J Neurooncol"},{"issue":"6","key":"1850_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/pharmaceutics14061283","volume":"14","author":"WM Pardridge","year":"2022","unstructured":"Pardridge WM. A historical review of brain drug delivery. Pharmaceutics. 2022;14(6):1283.","journal-title":"Pharmaceutics"},{"issue":"23","key":"1850_CR7","doi-asserted-by":"publisher","first-page":"12654","DOI":"10.3390\/ijms222312654","volume":"22","author":"F Mo","year":"2021","unstructured":"Mo F, Pellerino A, Soffietti R, et al. Blood-brain barrier in brain tumors: biology and clinical relevance. Int J Mol Sci. 2021;22(23):12654.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1850_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/ijms23031711","volume":"23","author":"EN Mathew","year":"2022","unstructured":"Mathew EN, Berry BC, Yang HW, et al. Delivering therapeutics to glioblastoma: overcoming biological constraints. Int J Mol Sci. 2022;23(3):1711.","journal-title":"Int J Mol Sci"},{"key":"1850_CR9","doi-asserted-by":"publisher","first-page":"654921","DOI":"10.3389\/fonc.2021.654921","volume":"11","author":"E Cooper","year":"2021","unstructured":"Cooper E, Choi PJ, Denny WA, et al. The use of heptamethine cyanine dyes as drug-conjugate systems in the treatment of primary and metastatic brain tumors. Front Oncol. 2021;11:654921.","journal-title":"Front Oncol"},{"issue":"1","key":"1850_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","volume":"10","author":"F Sonvico","year":"2018","unstructured":"Sonvico F, Clementino A, Buttini F, et al. Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting. Pharmaceutics. 2018;10(1):34.","journal-title":"Pharmaceutics"},{"issue":"2","key":"1850_CR11","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11095-011-0641-0","volume":"29","author":"Q Liu","year":"2012","unstructured":"Liu Q, Shen Y, Chen J, et al. Nose-to-brain transport pathways of wheat germ agglutinin conjugated PEG-PLA nanoparticles. Pharm Res. 2012;29(2):546\u201358.","journal-title":"Pharm Res"},{"key":"1850_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","volume":"270","author":"PC Pires","year":"2018","unstructured":"Pires PC, Santos AO. Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies. J Control Release Off J Control Release Soc. 2018;270:89\u2013100.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"11","key":"1850_CR13","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/C8CS00805A","volume":"48","author":"W Tang","year":"2019","unstructured":"Tang W, Fan W, Lau J, et al. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics. Chem Soc Rev. 2019;48(11):2967\u20133014.","journal-title":"Chem Soc Rev"},{"issue":"4","key":"1850_CR14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s13346-020-00747-y","volume":"10","author":"PG Upadhaya","year":"2020","unstructured":"Upadhaya PG, Pulakkat S, Patravale VB. Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management. Drug Deliv Transl Res. 2020;10(4):1044\u201356.","journal-title":"Drug Deliv Transl Res"},{"key":"1850_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release Off J Control Release Soc. 2018;281:139\u201377.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"1","key":"1850_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1517\/17425247.2012.636801","volume":"9","author":"S Bahadur","year":"2012","unstructured":"Bahadur S, Pathak K. Physicochemical and physiological considerations for efficient nose-to-brain targeting. Expert Opin Drug Deliv. 2012;9(1):19\u201331.","journal-title":"Expert Opin Drug Deliv"},{"key":"1850_CR17","doi-asserted-by":"publisher","first-page":"114285","DOI":"10.1016\/j.colsurfb.2024.114285","volume":"245","author":"V Deshmukh","year":"2025","unstructured":"Deshmukh V, Pathan NS, Haldar N, et al. Exploring intranasal drug delivery via nanocarriers: a promising glioblastoma therapy. Colloids Surf B Biointerfaces. 2025;245:114285.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1850_CR18","doi-asserted-by":"publisher","first-page":"114463","DOI":"10.1016\/j.addr.2022.114463","volume":"188","author":"Y Cai","year":"2022","unstructured":"Cai Y, Qi J, Lu Y, et al. The in vivo fate of polymeric micelles. Adv Drug Deliv Rev. 2022;188:114463.","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"1850_CR19","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/polym14224839","volume":"14","author":"G-W Jin","year":"2022","unstructured":"Jin G-W, Rejinold NS, Choy J-H. Multifunctional polymeric micelles for cancer therapy. Polymers. 2022;14(22):4839.","journal-title":"Polymers"},{"issue":"1","key":"1850_CR20","first-page":"108","volume":"2","author":"J-C Olivier","year":"2005","unstructured":"Olivier J-C. Drug transport to brain with targeted nanoparticles. NeuroRx J Am Soc Exp Neurother. 2005;2(1):108\u201319.","journal-title":"NeuroRx J Am Soc Exp Neurother"},{"key":"1850_CR21","first-page":"1057","volume":"5","author":"RZ Xiao","year":"2010","unstructured":"Xiao RZ, Zeng ZW, Zhou GL, et al. Recent advances in PEG\u2013PLA block copolymer nanoparticles. Int J Nanomedicine. 2010;5:1057\u201365.","journal-title":"Int J Nanomedicine"},{"issue":"24","key":"1850_CR22","first-page":"1112","volume":"8","author":"SK Sahoo","year":"2003","unstructured":"Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov. 2003;8(24):1112\u201320.","journal-title":"Drug Discov"},{"issue":"9","key":"1850_CR23","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1007\/s11095-014-1347-x","volume":"31","author":"JG Marques","year":"2014","unstructured":"Marques JG, Gaspar VM, Markl D, et al. Co-delivery of Sildenafil (Viagra(\u00ae)) and Crizotinib for synergistic and improved anti-tumoral therapy. Pharm Res. 2014;31(9):2516\u201328.","journal-title":"Pharm Res"},{"issue":"1","key":"1850_CR24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/jps.24234","volume":"104","author":"Y Wei","year":"2015","unstructured":"Wei Y, Xu S, Wang F, et al. A novel combined micellar system of lapatinib and Paclitaxel with enhanced antineoplastic effect against human epidermal growth factor receptor-2 positive breast tumor in vitro. J Pharm Sci. 2015;104(1):165\u201377.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1850_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1021\/acs.molpharmaceut.6b00872","volume":"14","author":"C-F Mu","year":"2017","unstructured":"Mu C-F, Xiong Y, Bai X, et al. Codelivery of ponatinib and SAR302503 by active bone-targeted polymeric micelles for the treatment of therapy-resistant chronic myeloid leukemia. Mol Pharm. 2017;14(1):274\u201383.","journal-title":"Mol Pharm"},{"issue":"2","key":"1850_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/0894268041457183","volume":"17","author":"A Vila","year":"2004","unstructured":"Vila A, S\u00e1nchez A, Evora C, et al. PEG-PLA nanoparticles as carriers for nasal vaccine delivery. J Aerosol Med Off J Int Soc Aerosols Med. 2004;17(2):174\u201385.","journal-title":"J Aerosol Med Off J Int Soc Aerosols Med"},{"issue":"18","key":"1850_CR27","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","volume":"27","author":"X Gao","year":"2006","unstructured":"Gao X, Tao W, Lu W, et al. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials. 2006;27(18):3482\u201390.","journal-title":"Biomaterials"},{"issue":"6","key":"1850_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2217\/cns.15.30","volume":"4","author":"E Le Rhun","year":"2015","unstructured":"Le Rhun E, Chamberlain MC, Zairi F, et al. Patterns of response to crizotinib in recurrent glioblastoma according to ALK and MET molecular profile in two patients. CNS Oncol. 2015;4(6):381\u20136.","journal-title":"CNS Oncol"},{"issue":"3","key":"1850_CR29","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1200\/JCO.2011.38.4586","volume":"30","author":"AS Chi","year":"2012","unstructured":"Chi AS, Batchelor TT, Kwak EL, et al. Rapid radiographic and clinical improvement after treatment of a MET-amplified recurrent glioblastoma with a mesenchymal-epithelial transition inhibitor. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(3):e30-33.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"1850_CR30","doi-asserted-by":"publisher","first-page":"6140","DOI":"10.1021\/acs.molpharmaceut.3c00496","volume":"20","author":"KM Pflug","year":"2023","unstructured":"Pflug KM, Lee DW, Tripathi A, et al. Cyanine dye conjugation enhances crizotinib localization to intracranial tumors, attenuating NF-\u03baB-Inducing kinase activity and glioma progression. Mol Pharm. 2023;20(12):6140\u201350.","journal-title":"Mol Pharm"},{"issue":"5848","key":"1850_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1126\/science.1142946","volume":"318","author":"JM Stommel","year":"2007","unstructured":"Stommel JM, Kimmelman AC, Ying H, et al. Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science. 2007;318(5848):287\u201390.","journal-title":"Science"},{"issue":"9","key":"1850_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s40263-017-0456-6","volume":"31","author":"M Westphal","year":"2017","unstructured":"Westphal M, Maire CL, Lamszus K. EGFR as a target for glioblastoma treatment: an unfulfilled promise. CNS Drugs. 2017;31(9):723\u201335.","journal-title":"CNS Drugs"},{"issue":"4","key":"1850_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12272-020-01232-3","volume":"43","author":"G Kim","year":"2020","unstructured":"Kim G, Ko YT. Small molecule tyrosine kinase inhibitors in glioblastoma. Arch Pharm Res. 2020;43(4):385\u201394.","journal-title":"Arch Pharm Res"},{"issue":"8","key":"1850_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/1061186X.2017.1419357","volume":"26","author":"K Greish","year":"2018","unstructured":"Greish K, Jasim A, Parayath N, et al. Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme. J Drug Target. 2018;26(8):692\u2013708.","journal-title":"J Drug Target"},{"issue":"7","key":"1850_CR35","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1021\/acs.bioconjchem.0c00302","volume":"31","author":"PJ Choi","year":"2020","unstructured":"Choi PJ, Park TIH, Cooper E, et al. Heptamethine cyanine dye mediated drug delivery: hype or hope. Bioconjug Chem. 2020;31(7):1724\u201339.","journal-title":"Bioconjug Chem"},{"issue":"9","key":"1850_CR36","first-page":"412","volume":"75","author":"X-G Yang","year":"2020","unstructured":"Yang X-G, Li Y-F, Wang Y-J, et al. Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells. Pharm. 2020;75(9):412\u20136.","journal-title":"Pharm"},{"issue":"10","key":"1850_CR37","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1039\/D4BM00003J","volume":"12","author":"J Liu","year":"2024","unstructured":"Liu J, Zhang J, Zhang Y, et al. A mitochondria-targeting heptamethine cyanine-chlorambucil formulated polymeric nanoparticle to potentiate native tumor chemotherapeutic efficacy. Biomater Sci. 2024;12(10):2614\u201325.","journal-title":"Biomater Sci"},{"key":"1850_CR38","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jconrel.2021.02.028","volume":"332","author":"X Yi","year":"2021","unstructured":"Yi X, Cao Z, Yuan Y, et al. Design and synthesis of a novel mitochondria-targeted osteosarcoma theranostic agent based on a PIM1 kinase inhibitor. J Control Release Off J Control Release Soc. 2021;332:434\u201347.","journal-title":"J Control Release Off J Control Release Soc"},{"issue":"22","key":"1850_CR39","first-page":"4120","volume":"24","author":"Y Guan","year":"2019","unstructured":"Guan Y, Zhang Y, Zou J, et al. Synthesis and biological evaluation of genistein-IR783 conjugate: cancer cell targeted delivery in MCF-7 for superior anti-cancer therapy. Mol Basel Switz. 2019;24(22):4120.","journal-title":"Mol Basel Switz"},{"key":"1850_CR40","doi-asserted-by":"publisher","first-page":"7169","DOI":"10.2147\/IJN.S325322","volume":"16","author":"A Raveendran","year":"2021","unstructured":"Raveendran A, Poilil Surendran S, Ser J, et al. heptamethine cyanine dye MHI-148-mediated drug delivery system to enhance the anticancer efficiency of paclitaxel. Int J Nanomedicine. 2021;16:7169\u201380.","journal-title":"Int J Nanomedicine"},{"issue":"23","key":"1850_CR41","doi-asserted-by":"publisher","first-page":"127557","DOI":"10.1016\/j.bmcl.2020.127557","volume":"30","author":"X Yang","year":"2020","unstructured":"Yang X, Hou Z, Wang D, et al. Design, synthesis and biological evaluation of novel heptamethine cyanine dye-erlotinib conjugates as antitumor agents. Bioorg Med Chem Lett. 2020;30(23):127557.","journal-title":"Bioorg Med Chem Lett"},{"issue":"25","key":"1850_CR42","doi-asserted-by":"publisher","first-page":"6612","DOI":"10.1016\/j.biomaterials.2010.05.007","volume":"31","author":"C Zhang","year":"2010","unstructured":"Zhang C, Liu T, Su Y, et al. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials. 2010;31(25):6612\u20137.","journal-title":"Biomaterials"},{"issue":"1","key":"1850_CR43","doi-asserted-by":"publisher","first-page":"vdac166","DOI":"10.1093\/noajnl\/vdac166","volume":"4","author":"E Cooper","year":"2022","unstructured":"Cooper E, Woolf Z, Swanson MEV, et al. Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue. Neuro-Oncol Adv. 2022;4(1):vdac166.","journal-title":"Neuro-Oncol Adv."},{"issue":"18","key":"1850_CR44","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1016\/j.bmcl.2019.07.051","volume":"29","author":"PJ Choi","year":"2019","unstructured":"Choi PJ, Cooper E, Schweder P, et al. The synthesis of a novel Crizotinib heptamethine cyanine dye conjugate that potentiates the cytostatic and cytotoxic effects of Crizotinib in patient-derived glioblastoma cell lines. Bioorg Med Chem Lett. 2019;29(18):2617\u201321.","journal-title":"Bioorg Med Chem Lett"},{"key":"1850_CR45","unstructured":"Research C for DE and. Q2(R1) Validation of analytical procedures: Text and methodology guidance for industry [Internet]. FDA; 2021. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q2r1-validation-analytical-procedures-text-and-methodology-guidance-industry.\u00a0Accessed 7 Aug 2024"},{"issue":"1","key":"1850_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1567201820666221214105836","volume":"21","author":"A Haasbroek-Pheiffer","year":"2024","unstructured":"Haasbroek-Pheiffer A, Viljoen A, Steenekamp J, et al. An ex vivo investigation on drug permeability of sheep nasal epithelial tissue membranes from the respiratory and olfactory regions. Curr Drug Deliv. 2024;21(1):115\u201325.","journal-title":"Curr Drug Deliv"},{"issue":"43","key":"1850_CR47","doi-asserted-by":"publisher","first-page":"40729","DOI":"10.1021\/acsomega.3c05802","volume":"8","author":"R Joy","year":"2023","unstructured":"Joy R, Siddiqua H, Sharma S, et al. Block copolymer encapsulation of disarib, an inhibitor of BCL2 for improved chemotherapeutic potential. ACS Omega. 2023;8(43):40729\u201340.","journal-title":"ACS Omega"},{"issue":"1","key":"1850_CR48","first-page":"142","volume":"18","author":"E Khodaverdi","year":"2019","unstructured":"Khodaverdi E, Tayarani-Najaran Z, Minbashi E, et al. Docetaxel-loaded mixed micelles and polymersomes composed of poly (caprolactone)-poly (ethylene glycol) (PEG-PCL) and poly (lactic acid)-poly (ethylene glycol) (PEG-PLA): preparation and in-vitro characterization. Iran J Pharm Res IJPR. 2019;18(1):142\u201355.","journal-title":"Iran J Pharm Res IJPR"},{"key":"1850_CR49","doi-asserted-by":"publisher","unstructured":"de Vries WC, Ravoo BJ. Vesicles and micelles. In: Kubik S editor. Supramolecular chemistry in water. Germany: Published by Wiley\u2010VCH; 2019. pp. 375\u2013411. https:\/\/doi.org\/10.1002\/9783527814923.ch10","DOI":"10.1002\/9783527814923.ch10"},{"key":"1850_CR50","doi-asserted-by":"publisher","first-page":"119776","DOI":"10.1016\/j.ijpharm.2020.119776","volume":"589","author":"A-T Chatzitaki","year":"2020","unstructured":"Chatzitaki A-T, Jesus S, Karavasili C, et al. Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety. Int J Pharm. 2020;589:119776.","journal-title":"Int J Pharm"},{"key":"1850_CR51","doi-asserted-by":"crossref","unstructured":"Mudalige T, Qu H, Van Haute D, et al. Chapter 11 - Characterization of nanomaterials: Tools and challenges. In: L\u00f3pez Rubio A, Fabra Rovira MJ, mart\u00ednez Sanz M, et al., editors. Nanomater Food Appl [Internet]. Elsevier; 2019. p. 313\u2013353. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780128141304000117.\u00a0Accessed 11 Oct 2024","DOI":"10.1016\/B978-0-12-814130-4.00011-7"},{"issue":"12","key":"1850_CR52","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1039\/D3MH00717K","volume":"10","author":"SK Filippov","year":"2023","unstructured":"Filippov SK, Khusnutdinov R, Murmiliuk A, et al. Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results. Mater Horiz. 2023;10(12):5354\u201370.","journal-title":"Mater Horiz"},{"issue":"10","key":"1850_CR53","doi-asserted-by":"publisher","first-page":"6957","DOI":"10.1166\/jnn.2018.15458","volume":"18","author":"SP Yeap","year":"2018","unstructured":"Yeap SP, Lim J, Ngang HP, et al. Role of particle-particle interaction towards effective interpretation of Z-average and particle size distributions from dynamic light scattering (DLS) analysis. J Nanosci Nanotechnol. 2018;18(10):6957\u201364.","journal-title":"J Nanosci Nanotechnol"},{"key":"1850_CR54","doi-asserted-by":"publisher","first-page":"101631","DOI":"10.1016\/j.apmt.2022.101631","volume":"29","author":"ML Formica","year":"2022","unstructured":"Formica ML, Real DA, Picchio ML, et al. On a highway to the brain: a review on nose-to-brain drug delivery using nanoparticles. Appl Mater Today. 2022;29:101631.","journal-title":"Appl Mater Today"},{"key":"1850_CR55","unstructured":"Suspension Stability: The importance of Zeta Potential and Particle Size [Internet]. Available from: https:\/\/www.malvernpanalytical.com\/en\/learn\/knowledge-center\/application-notes\/an101130suspensionstability.\u00a0Accessed 2 Jan 2025"},{"issue":"26","key":"1850_CR56","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1016\/j.biomaterials.2010.05.027","volume":"31","author":"R Kedmi","year":"2010","unstructured":"Kedmi R, Ben-Arie N, Peer D. The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation. Biomaterials. 2010;31(26):6867\u201375.","journal-title":"Biomaterials"},{"issue":"1\u20132","key":"1850_CR57","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijpharm.2014.03.009","volume":"466","author":"A Ouahab","year":"2014","unstructured":"Ouahab A, Cheraga N, Onoja V, et al. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study. Int J Pharm. 2014;466(1\u20132):233\u201345.","journal-title":"Int J Pharm"},{"key":"1850_CR58","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jcis.2022.06.126","volume":"626","author":"TMM Ways","year":"2022","unstructured":"Ways TMM, Filippov SK, Maji S, et al. Mucus-penetrating nanoparticles based on chitosan grafted with various non-ionic polymers: Synthesis, structural characterisation and diffusion studies. J Colloid Interface Sci. 2022;626:251\u201364.","journal-title":"J Colloid Interface Sci"},{"issue":"5","key":"1850_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40005-012-0040-5","volume":"42","author":"YJ Jung","year":"2012","unstructured":"Jung YJ, Yoon J-H, Kang NG, et al. Diffusion properties of different compounds across various synthetic membranes using Franz-type diffusion cells. J Pharm Investig. 2012;42(5):271\u20137.","journal-title":"J Pharm Investig"},{"issue":"3","key":"1850_CR60","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.pharmthera.2012.03.003","volume":"134","author":"S Grassin-Delyle","year":"2012","unstructured":"Grassin-Delyle S, Buenestado A, Naline E, et al. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacol Ther. 2012;134(3):366\u201379.","journal-title":"Pharmacol Ther"},{"key":"1850_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.msec.2018.11.035","volume":"96","author":"JP Abriata","year":"2019","unstructured":"Abriata JP, Turatti RC, Luiz MT, et al. Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles. Mater Sci Eng C Mater Biol Appl. 2019;96:347\u201355.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1850_CR62","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.colsurfb.2016.01.032","volume":"141","author":"JO Eloy","year":"2016","unstructured":"Eloy JO, Petrilli R, Topan JF, et al. Co-loaded paclitaxel\/rapamycin liposomes: development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Colloids Surf B Biointerfaces. 2016;141:74\u201382.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"2","key":"1850_CR63","first-page":"270","volume":"11","author":"Y Yu","year":"2019","unstructured":"Yu Y, Peng L, Liao G, et al. Noncovalent complexation of amphotericin B with Poly(\u03b2-Amino Ester) derivates for treatment of C. Neoformans Infection Polymers. 2019;11(2):270.","journal-title":"Neoformans Infection Polymers"},{"key":"1850_CR64","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejpb.2021.05.024","volume":"165","author":"E Trenkenschuh","year":"2021","unstructured":"Trenkenschuh E, Friess W. Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization. Eur J Pharm Biopharm. 2021;165:345\u201360.","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"1850_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1699-0463.1968.tb03502.x","volume":"74","author":"J Pont\u00e9n","year":"1968","unstructured":"Pont\u00e9n J, Macintyre EH. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74(4):465\u201386.","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"354","key":"1850_CR66","doi-asserted-by":"publisher","first-page":"354re3","DOI":"10.1126\/scitranslmed.aaf6853","volume":"8","author":"M Allen","year":"2016","unstructured":"Allen M, Bjerke M, Edlund H, et al. Origin of the U87MG glioma cell line: Good news and bad news. Sci Transl Med. 2016;8(354):354re3.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1850_CR67","first-page":"105","volume":"22","author":"D Giakoumettis","year":"2018","unstructured":"Giakoumettis D, Kritis A, Foroglou N. C6 cell line: the gold standard in glioma research. Hippokratia. 2018;22(3):105\u201312.","journal-title":"Hippokratia"},{"issue":"7","key":"1850_CR68","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2176\/nmc.27.581","volume":"27","author":"I Takeshita","year":"1987","unstructured":"Takeshita I, Takaki T, Kuramitsu M, et al. Characteristics of an established human glioma cell line, KNS-42. Neurol Med Chir (Tokyo). 1987;27(7):581\u20137.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"4","key":"1850_CR69","doi-asserted-by":"publisher","first-page":"e5209","DOI":"10.1371\/journal.pone.0005209","volume":"4","author":"DA Bax","year":"2009","unstructured":"Bax DA, Little SE, Gaspar N, et al. Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS ONE. 2009;4(4):e5209.","journal-title":"PLoS ONE"},{"issue":"9","key":"1850_CR70","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s11095-011-0440-7","volume":"28","author":"T Kanazawa","year":"2011","unstructured":"Kanazawa T, Taki H, Tanaka K, et al. Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration. Pharm Res. 2011;28(9):2130\u20139.","journal-title":"Pharm Res"},{"issue":"1","key":"1850_CR71","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1080\/10717544.2018.1494226","volume":"25","author":"L Chu","year":"2018","unstructured":"Chu L, Wang A, Ni L, et al. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Deliv. 2018;25(1):1634\u201341.","journal-title":"Drug Deliv"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-025-01850-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-025-01850-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:03:44Z","timestamp":1759932224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-025-01850-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1850"],"URL":"https:\/\/doi.org\/10.1007\/s13346-025-01850-8","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"30 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent to publish"}},{"value":"All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}